The major conventional hypoglycemic drugs used for the treatment of diabetes include diguanides, sulphonylureas, SGLT2 inhibitors, DPP-4 inhibitors, GLP-1 receptor agonists, alpha glucosidase inhibitors, and thiazolidinediones (TZDs), etc. (Table 1). The gene discussed is SLC5A2; the disease is diabetes mellitus.